Covid-19 roundup: J&J charts swift path to 1B vaccine doses; Embassy cable spotlights possible Wuhan lab connection to coronavirus
J&J, the first large pharmaceutical company to unveil its performance in the first quarter, acknowledged the coronavirus pandemic has had a sharp impact across its full-year guidance and offered some fresh details on its Covid-19 vaccine in development.
J&J, like its peers, is attempting to do in six to 12 months what usually takes 5 to 7 years, CEO Alex Gorsky reminded analysts on a conference call on Monday.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.